Calliditas Therapeutics' Shares Gain Following Conditional Marketing Authorization From European Commission For Kidney Disease Candidate
July 15, 2022 at 12:15 PM EDT
The European Commission (EC) has granted conditional marketing authorization for Calliditas Therapeutics’s (NASDAQ: CALT) Kinpeygo ...